Kolmogorov–Smirnov statistical test for analysis of ZAP‐70 expression in B‐CLL, compared with quantitative PCR and IgVH mutation status
- 15 July 2006
- journal article
- research article
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 70B (4), 302-308
- https://doi.org/10.1002/cyto.b.20122
Abstract
Background: ZAP‐70 has been proposed as a surrogate marker for immunoglobulin heavy‐chain variable region (IgVH) mutation status, which is known as a prognostic marker in B‐cell chronic lymphocytic leukemia (CLL). The flow cytometric analysis of ZAP‐70 suffers from difficulties in standardization and interpretation. We applied the Kolmogorov–Smirnov (KS) statistical test to make analysis more straightforward. Methods: We examined ZAP‐70 expression by flow cytometry in 53 patients with CLL. Analysis was performed as initially described by Crespo et al. (New England J Med 2003; 348:1764‐1775) and alternatively by application of the KS statistical test comparing T cells with B cells. Receiver‐operating‐characteristics (ROC)‐curve analyses were performed to determine the optimal cut‐off values for ZAP‐70 measured by the two approaches. ZAP‐70 protein expression was compared with ZAP‐70 mRNA expression measured by a quantitative PCR (qPCR) and with the IgVH mutation status. Results: Both flow cytometric analyses correlated well with the molecular technique and proved to be of equal value in predicting the IgVH mutation status. Applying the KS test is reproducible, simple, straightforward, and overcomes a number of difficulties encountered in the Crespo‐method. Conclusions: The KS statistical test is an essential part of the software delivered with modern routine analytical flow cytometers and is well suited for analysis of ZAP‐70 expression in CLL. © 2006 International Society for Analytical CytologyKeywords
This publication has 22 references indexed in Scilit:
- Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaEmerging Therapeutic Targets, 2005
- ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2004
- ZAP-70 expression and prognosis in chronic lymphocytic leukaemiaThe Lancet, 2004
- ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemiaLeukemia, 2003
- ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2003
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic LeukemiaThe Journal of Experimental Medicine, 2001
- Improvement of the Chronic Lymphocytic Leukemia Scoring System With the Monoclonal Antibody SN8(CD79b)American Journal of Clinical Pathology, 1997
- A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer, 1981
- Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources.Journal of Histochemistry & Cytochemistry, 1977